期刊文献+

细胞毒药物与肿瘤血管生成 被引量:7

Cytotoxic Drugs and Its Anti-angiogenesis
原文传递
导出
摘要 细胞毒药物在传统抗肿瘤化疗中运用较多,然而由于高剂量的使用难免会引起毒副作用和耐药性。为了使细胞毒药物能安全有效地治疗肿瘤,近年来,人们研究了合理运用细胞毒药物的方法,使其作用从直接杀死肿瘤细胞转变为针对肿瘤血管生成。本文就近十年来在该方面的研究作一综述。 Cytotoxic drugs are widely used in traditional antitumor chemotherapy, while the using of high dose will inevitably cause serious side effects and drug resistance. For many years, in order to make cytotoxic drugs be used safely and effectively, researchers have investigated the rational use of cytotoxic drugs, which can turn the mode of action of these drugs from killing tumor cells directly to inhibiting tumor angiogenesis. This article surveys the advances in the rational use of cytotoxic drugs.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2011年第7期618-622,共5页 Chinese Journal of Modern Applied Pharmacy
基金 江苏省高校"青蓝工程"资助项目(2008) 江苏省自然科学基金项目(BK2010436)
关键词 细胞毒药物 合理应用 血管生成抑制 节律疗法 cytotoxic drugs rational use angiogenesis inhibition metronomic chemotherapy
  • 相关文献

参考文献43

  • 1FARBER S, DIAMOND L K, MERCER R D. Temporary remissions in acute leukemia in children produced by folic acid antagonist 4-aminopteroylglutamic acid (aminopterin) [J]. N Engl J Med, 1948, 238(23): 787-793.
  • 2FOLKMAN J. Tumor angiogenesis: therapeutic implications [J]. N Engl J Med, 1971,285(21): 1182-1186.
  • 3BALUK P, HASHIZUME H, MCDONALD D M. Cellular abnormalities of blood vessels as targets in cancer [J]. Curr Opin Genet Dev, 2005, 15(1): 102-111.
  • 4HANAHAN D, FOTTKMAN J. Pattems and emerging mechanisms of the angiogenic switch during tumorigenesis [J]. Cell, 1996, 86(3): 353-364.
  • 5CHRISTOFORI G. New signals from the invasive front [J]. Nature, 2006, 441(7092): 444-450.
  • 6BAI R Z, WU Y, LIU Q, et al. Suppression of lung cancer in murine model: treated by combination of recombinant human endostsatin adenovirus with low-dose cisplatin [J]. J Exp Clin Cancer Res, 2009, 28(I): 31-39.
  • 7HANAHAN D, BERGERS G, BERGSLAND E. Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice [J]. J Clin Invest, 2000, 105(8): 1045-1047.
  • 8EMMENEGGER U, MAN S, SHAKED Y, et al. A comparative analysis of low-dose metronomic cyclophosphamide reveals absent or lowgrade toxicity on tissues highly sensitive to the toxic effects of maximum tolerated dose regimens [J]. Cancer Res, 2004, 64(11): 3994-4000.
  • 9KABBINAVAR F, HURWITZ H I, FEHRENBACHER L, et al. Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer [J]. J Clin Oncol, 2003, 21(1): 60-65.
  • 10ZHOU Q, GUO P, GALLO J M. Impact of angiogenesis inhibition by sunitinib on tumor distribution of temozolomide [J]. Clin Cancer Res, 2008, 14(5): 1540-1549.

同被引文献65

引证文献7

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部